James J. Crawford
ORCID：0000-0002-6408-8246
发表论文 154 篇 · 总被引 6447 次 · h-index 42
代表论文
- Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities (2019 · Trends in cancer · 被引 446)
- Optimized arylomycins are a new class of Gram-negative antibiotics (2018 · Nature · 被引 369)
- Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development (2018 · Journal of Medicinal Chemistry · 被引 258)
- An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance (2023 · Nature Cancer · 被引 212)
- Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling (2020 · Cell Reports · 被引 179)
- NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus (2018 · Nature Communications · 被引 128)